The Central Drug Standard Control Organisation (CDSCO) vide notification dated 24.05.2021, informed that Government of India has revised clinical guidance for management of Adult COVID-19 patients on 19.05.2021.
“Convalescent plasma” (off label) as investigational therapy has been taken out of the clinical management protocol.
This initiative aligns with the objectives of the National Education Policy (NEP) 2020, aiming to foster a more flexible, inclusive, and multidisciplinary higher education system.
These measures are expected to strengthen GIFT IFSC’s position as a globally competitive bullion trading hub and reflect IFSCA’s commitment to fostering a robust and
SEBI tightens the ESG rating ecosystem balancing confidentiality, transparency, and stakeholder rights.
Regulated Entities are advised to use PRAVAAH for submitting applications for regulatory authorisations.
Stay up-to-date with the latest regulatory developments from Legality Alerts, directly in your inbox. Never miss another important regulatory compliance news alert.
Solutions
Resources
